Rare condition

Germ cell tumor

00

studies recruiting now

checking live

00

studies registered in total

checking live

00

countries with a recruiting site

checking live

00

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Germ cell tumor study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

A group of conditions, not a single diagnosis

Orphanet classifies “Germ cell tumor” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

2 approved treatments and 21 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Ifosfamide (Ifex)Approved: Bleomycin (Bleo)
Phase 3Aprepitant (Aponvie)
Phase 2Gefitinib (Gefitinib mylan)
Phase 2Everolimus (Afinitor)
Phase 2Paclitaxel (Abraxane)
Phase 2Durvalumab (Imfinzi)
Phase 2Erlotinib
Phase 2Epirubicin
Phase 2Sunitinib (Sunitinib accord)

+ 13 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).